Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study Meeting Abstract

  

Authors:	Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; Kris, M. G.; Ginsberg, M. S.; Chow, A.; Quintanal-Villalonga, A.; Shah, S. P.; Rudin, C. M.; Rusch, V. W.; Adusumilli, P. S.; Zauderer, M. G.
Abstract Title:	Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
Meeting Title:	2024 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	16 Suppl.
Meeting Dates:	2024 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001275557401798
PROVIDER:	wos
DOI:	10.1200/JCO.2024.42.16_suppl.8003
Notes:	Meeting Abstract: 8003 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218724